Webinar title: "Human immunity to SARS-CoV-2"

In this webinar, Dr. Prahbu Arunachalam reviews a protein biomarker study that revealed how the immune system goes awry leading to severe disease during SARS-CoV-2 infections, as well as identified potential prognostic biomarkers that may serve as therapeutic targets for the disease.

Watch the webinar to learn more about:

• How Dr. Arunachalam and colleagues used a combination of single-cell transcriptomics, plasma proteomics and mass cytometry to study the immune response to severe COVID-19
• The complex immune response to severe SARS-CoV-2 infection, which involves an intricate interplay between the peripheral innate immune response and pro-inflammatory immune response in the lung
• Olink analysis of inflammatory proteins in the blood of COVID-19 patients that identified three novel proteins associated with disease severity which could serve as potential therapeutic targets

Speaker